From 2013 to 2023, healthcare expenditure on over-the-counter medicines in France showed a declining trend with some fluctuations. There was a significant drop from 2013 to 2020, with the most notable decreases occurring between 2019 and 2021. Despite a recovery in 2022, the expenditure slightly decreased in 2023, standing at 1.08 units of Total Current Health Expenditure. The compound annual growth rate (CAGR) over the last five years was negative at -2.57%.

Future trends to watch for:

Continued decline in healthcare expenditure on over-the-counter medicines, with forecasted negative CAGR of -2.4% over the next five years.
Potential impact of healthcare policies and market dynamics affecting consumer behavior.
Technological advancements and changing retail landscapes potentially altering market conditions.
Emergence of new health trends and preferences influencing over-the-counter medicine sales.